IP Verse

Aptalis Pharma Limited opposition analysis

COMPANY ANALYSIS

Patent:

Grant Date:

Oct 7, 2020

Title:

High Potency Pancreatin Pharmaceutical Compositions

Oppositions:

Patent:

Grant Date:

Aug 15, 2018

Title:

Pancreatic Enzyme Compositions And Methods For Treating Pancreatitis And Pancreatic Insufficiency

Oppositions:

Patent:

Grant Date:

Nov 8, 2017

Title:

Enteric Coated, Low-Strength Pancrelipase Formulations

Oppositions:

Patent Number	Grant Date	Title	Total Oppositions
EP3003360	Oct 7, 2020	High Potency Pancreatin Pharmaceutical Compositions	1
EP2477645	Aug 15, 2018	Pancreatic Enzyme Compositions And Methods For Treating Pancreatitis And Pancreatic Insufficiency	1
EP2818160	Nov 8, 2017	Enteric Coated, Low-Strength Pancrelipase Formulations	1

MATHYS & SQUIRE LLP

CAMULON LIMITED

Feel free to send us a message here and we will get back to you